Jyoti Patel
Co-chair on the ASCO Living Guideline for therapy of stage IV NSCLC with driver alterations; affiliated with Northwestern University.
Top 3 podcasts with Jyoti Patel
Ranked by the Snipd community
Feb 27, 2025 • 15min
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.3 Part 2
Dr. Jyoti Patel, co-chair on the ASCO Living Guideline for NSCLC therapy and an expert from Northwestern University, shares crucial updates on treating stage IV non-small cell lung cancer (NSCLC) with driver alterations. She discusses the pivotal role of osimertinib as a primary treatment and the introduction of innovative alternatives like amivantumab and luzertinib. The conversation also covers the significance of personalized treatment strategies, the challenges of resistance, and the ongoing need for updated clinical guidelines to enhance patient care.
Feb 28, 2024 • 14min
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.3 Part 2
Dr. Natash Leighl and Dr. Jyoti Patel discuss the updated living guideline for stage IV NSCLC with driver alterations, covering therapies for EGFR, ALK, ROS1, BRAFV600E, MET exon skipping mutation, RET rearrangement, NTRK rearrangement, HER2, and KRAS G12C. They emphasize key changes, recent trials, importance of biomarker testing, and impact on clinicians and patients. Stay tuned for future updates.
Feb 28, 2024 • 10min
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.3 Part 1
Dr. Patel and Dr. Leighl discuss updated guidelines for treating stage IV NSCLC without driver alterations, focusing on biomarker testing and treatment options. They explore the impact of immunotherapy over chemotherapy in first-line treatment and emphasize the importance of patient-clinician communication to improve outcomes.
